Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing
Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the newest massive pharma firm to succeed in a ...
Tag: biotechs
A CAR-T biotech’s dramatic turnaround
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Road, and ...
Cytokinetics heart drug wins FDA approval, the biotech’s first
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Readout LOUD podcast: Biotech’s year in review
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Biogen CEO is shopping for biotechs: ‘We will be doing deals’
SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially ...
Trump taps RFK Jr. for HHS: Scientists, pharma, biotechs react
Leaders throughout the biopharma world and scientific community struggled to process news on Thursday that President-elect Donald Trump has tapped ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!